FTXH 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

FTXH

First Trust Nasdaq Pharmaceuticals ETF

收盤價 10月26日 4:00 PM ET（韓國 10/27 05:00）

$42.81

+0.13 ▲ +0.32%

10月26日 5:53 PM ET（韓國 10/27 06:53）

$42.81

+0.00 +0.00%

上升通道阻力線 45.34 支撐線 41.05 維持由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.6%	Return% 1Y ⓘ	46.54%	Total Holdings ⓘ	51	Perf Week ⓘ	2.93%	Volume ⓘ	57,624
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$1.14B	Return% 3Y ⓘ	20.46%	NAV ⓘ	$42.65	Perf Month ⓘ	2.74%	Avg Volume ⓘ	0.67M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	$0.29 (0.68%)	Return% 5Y ⓘ	12.05%	52W High ⓘ	-1.63%	Perf Quarter ⓘ	7.87%	Rel Volume ⓘ	0.09
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	15.1% 16.86%	Return% 10Y ⓘ	9.5%	52W Low ⓘ	45.59%	Perf Half Y ⓘ	27.81%	Prev Close ⓘ	$42.68
IPO ⓘ	2016/9/22	Flows% 1M ⓘ	3.53%	Return% SI ⓘ	9.06%	RSI (14) ⓘ	61.18	Perf YTD ⓘ	29.96%	Price ⓘ	$42.81
Beta ⓘ	0.46	Flows% 3M ⓘ	28.81%	Flows% YTD ⓘ	855.26%	Flows% 1Y ⓘ	868.77%	Perf Year ⓘ	45.19%	Volatility(W/M) ⓘ	1.45% 1.77%
SMA20 ⓘ	3.07%	SMA50 ⓘ	3.17%	SMA200 ⓘ	15.73%	ATR ⓘ	0.72

ETF 簡介

First Trust Nasdaq Pharmaceuticals ETFFTXH | NASD | 一般 ETF 查看深度分析

First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals IndexTM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.

FTXH ETF 一覽

0.6% 越低越好

$1.1B 管理資產

51檔

0.68% 季配

掛牌日 2016年

管理方式追蹤指數

發行公司 First Trust

主要持有標的持有 51 檔

前 10 大持股占 基金的 53%